$NKLA
Nikola Corp Stock $nkla

$nkla Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000173128921000102 Filed on August 03, 2021

Income Statement

Concept	2021 Q2	2020 Q2	2020 Q1
Revenue	$0.00	$36.00K	$58.00K
YoY Change	-100.0%	176.92%	-53.23%
Cost Of Revenue	$0.00	$30.00K	$43.00K
YoY Change	-100.0%	25.0%	-30.65%
Gross Profit	$0.00	$6.000K	$15.00K
YoY Change	-100.0%	-154.55%	-75.81%
Gross Profit Margin		16.67%	25.86%
Selling, General & Admin	$70.67M	$44.10M	$7.935M
YoY Change	60.24%	725.3%	22.06%
% of Gross Profit		735066.67%	52900.0%
Research & Development	$67.73M	$42.53M	$24.08M
YoY Change	59.26%	258.74%	2.91%
% of Gross Profit		708750.0%	160513.33%
Depreciation & Amortization	$1.900M	$1.500M	$1.408M
YoY Change	26.67%	650.0%
% of Gross Profit		25000.0%	9386.67%
Operating Expenses	$138.4M	$86.63M	$32.01M
YoY Change	59.76%	403.72%	7.07%
Operating Profit	-$138.4M	-$86.62M	-$32.00M
YoY Change	59.77%	403.36%	7.24%
Interest Expense	-$92.00K	$22.00K	$62.00K
YoY Change	-518.18%	-93.49%	-81.38%
% of Operating Profit
Other Income/Expense, Net	-$1.102M	-$23.00K	$114.0K
YoY Change	4691.3%	-355.56%	11300.0%
Pretax Income	-$142.1M	-$86.64M	-$33.15M
YoY Change	64.01%	416.83%	10.13%
Income Tax	$2.000K	$1.000K	$1.000K
% Of Pretax Income
Net Earnings	-$143.2M	-$115.8M	-$33.15M
YoY Change	23.71%	590.58%	10.13%
Net Earnings / Revenue		-321616.67%	-57148.28%
Basic Earnings Per Share	-$0.36	-$0.43	-$0.12
Diluted Earnings Per Share	-$0.36	-$0.43	-$0.12
COMMON SHARES
Basic Shares Outstanding	394.6M shares	303.8M shares	271.9M shares
Diluted Shares Outstanding	394.6M shares	303.8M shares	271.9M shares

Balance Sheet

Concept	2021 Q2	2020 Q2	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$632.7M	$698.4M	$1.200M
YoY Change	-9.41%	87200.0%	33.33%
Cash & Equivalents	$632.7M	$698.4M	$75.52M
Short-Term Investments
Other Short-Term Assets	$28.32M	$64.60M	$0.00
YoY Change	-56.15%	64500.0%	-100.0%
Inventory	$2.267M
Prepaid Expenses
Receivables		$424.0K
Other Receivables		$0.00
Total Short-Term Assets	$663.3M	$772.4M	$1.200M
YoY Change	-14.12%	85719.78%	20.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$166.4M	$59.86M
YoY Change	177.95%
Goodwill	$5.238M	$5.238M
YoY Change	0.0%
Intangibles	$50.00M	$62.48M
YoY Change	-19.98%
Long-Term Investments	$63.64M
YoY Change
Other Assets	$0.00	$14.76M	$238.4M
YoY Change	-100.0%	-93.77%	0.76%
Total Long-Term Assets	$301.9M	$152.7M	$238.3M
YoY Change	97.77%	-35.5%	0.72%
TOTAL ASSETS
Total Short-Term Assets	$663.3M	$772.4M	$1.200M
Total Long-Term Assets	$301.9M	$152.7M	$238.3M
Total Assets	$965.2M	$925.0M	$239.5M
YoY Change	4.34%	289.33%	0.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$58.06M	$7.600M	$100.0K
YoY Change	664.0%		0.0%
Accrued Expenses	$25.56M	$14.30M	$100.0K
YoY Change	78.77%	7050.0%	-50.0%
Deferred Revenue		$4.982M
YoY Change
Short-Term Debt	$0.00	$0.00	$400.0K
YoY Change
Long-Term Debt Due	$0.00	$4.100M
YoY Change	-100.0%
Total Short-Term Liabilities	$84.79M	$30.61M	$1.300M
YoY Change	177.01%	15204.5%	18.18%
LONG-TERM LIABILITIES
Long-Term Debt	$13.49M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$8.895M	$11.76M
YoY Change	-24.38%
Total Long-Term Liabilities	$22.39M	$11.76M	$0.00
YoY Change	90.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$84.79M	$30.61M	$1.300M
Total Long-Term Liabilities	$22.39M	$11.76M	$0.00
Total Liabilities	$107.2M	$43.45M	$1.300M
YoY Change	146.71%	14381.67%	8.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$823.6M	-$308.3M
YoY Change	167.16%
Common Stock	$40.00K	$36.00K
YoY Change	11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$844.8M	$829.9M	$193.5M
YoY Change
Total Liabilities & Shareholders Equity	$965.2M	$925.0M	$239.5M
YoY Change	4.34%	289.33%	0.8%

Cashflow Statement

Concept	2021 Q2	2020 Q2	2020 Q1
OPERATING ACTIVITIES
Net Income	-$143.2M	-$115.8M	-$33.15M
YoY Change	23.71%	590.58%	10.13%
Depreciation, Depletion And Amortization	$1.900M	$1.500M	$1.408M
YoY Change	26.67%	650.0%
Cash From Operating Activities	-$66.72M	-$45.02M	-$21.90M
YoY Change	48.21%	3284.96%	7199.0%
INVESTING ACTIVITIES
Capital Expenditures	-$40.27M	-$6.300M
YoY Change	539.16%
Acquisitions
YoY Change
Other Investing Activities	-$24.80M		$238.9M
YoY Change			-597300.0%
Cash From Investing Activities	-$65.07M	-$245.2M	-$1.439M
YoY Change	-73.46%	-19714.4%	3497.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$12.96M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	737.0K	668.9M	$13.15M
YoY Change	-99.89%
NET CHANGE
Cash From Operating Activities	-66.72M	-45.02M	-$21.90M
Cash From Investing Activities	-65.07M	-245.2M	-$1.439M
Cash From Financing Activities	737.0K	668.9M	$13.15M
Net Change In Cash	-131.1M	378.7M	-$10.19M
YoY Change	-134.61%	-473462.5%	2895.59%
FREE CASH FLOW
Cash From Operating Activities	-$66.72M	-$45.02M	-$21.90M
Capital Expenditures	-$40.27M	-$6.300M
Free Cash Flow	-$26.46M	-$38.72M
YoY Change	-31.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001731289
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38495
	dei	Entity Registrant Name EntityRegistrantName	Nikola Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4151153
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4141 E Broadway Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Phoenix
	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85040
	dei	City Area Code CityAreaCode	480
	dei	Local Phone Number LocalPhoneNumber	666-1038
	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	NKLA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	398253825	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	632694000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	840913000	USD
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4365000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	2267000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2021Q2	nkla	Prepaid In Kind Services Current PrepaidInKindServicesCurrent	18548000	USD
CY2020Q4	nkla	Prepaid In Kind Services Current PrepaidInKindServicesCurrent	46271000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9776000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5368000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	663285000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	896917000	USD
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4000000	USD
CY2021Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	16670000	USD
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	17687000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	166367000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	71401000	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	50000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	50050000	USD
CY2021Q2	us-gaap	Equity Method Investments EquityMethodInvestments	63639000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8420000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	5238000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	5238000	USD
CY2021Q2	us-gaap	Assets Assets	965199000	USD
CY2020Q4	us-gaap	Assets Assets	1053713000	USD
CY2021Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	58064000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	29364000	USD
CY2021Q2	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	26725000	USD
CY2020Q4	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	18809000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4100000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	84789000	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	52273000	USD
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13491000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13956000	USD
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	8895000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7335000	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	107185000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	73572000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	13237000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	397077561	shares
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	239000	USD
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	397077561	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	391041347	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	391041347	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	40000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	39000	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1668362000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1540037000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-823629000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-560174000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	844777000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	980141000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	965199000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1053713000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7300000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	94000	USD
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	30000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	73000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	0	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	6000	USD
	us-gaap	Gross Profit GrossProfit	0	USD
	us-gaap	Gross Profit GrossProfit	21000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67726000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42525000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	122889000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	66602000	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	70672000	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44104000	USD
	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	-1324000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	136099000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	52039000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	138398000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	86629000	USD
	us-gaap	Operating Expenses OperatingExpenses	258988000	USD
	us-gaap	Operating Expenses OperatingExpenses	118641000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-138398000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-86623000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-258988000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-118620000	USD
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-92000	USD
CY2020Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	22000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-101000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	84000	USD
CY2021Q2	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
CY2020Q2	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
CY2021Q2	us-gaap	Deposits Deposits	0	USD
CY2020Q4	us-gaap	Deposits Deposits	300000	USD
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2511000	USD
CY2020Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	29157000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1560000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	29157000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1102000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-23000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-883000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	91000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-142103000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-115781000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-261532000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-148926000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2021Q2	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-142105000	USD
CY2020Q2	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-115782000	USD
	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-261535000	USD
	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-148928000	USD
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1126000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1920000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-143231000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-115782000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-263455000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-148928000	USD
CY2021Q2	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	USD
CY2020Q2	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	13407000	USD
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	USD
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	13407000	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-143231000	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-143231000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-129189000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-129189000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-263455000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-263455000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-162335000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-162335000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	394577711	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	303785616	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	393390377	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	287822558	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	394577711	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	303785616	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	393390377	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	287822558	shares
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-143231000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-115782000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-263455000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-148928000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	78000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-235000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-143153000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-115782000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-263690000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-148928000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	912283000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1213000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2625000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	19139000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	52670000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-143231000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	78000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	844777000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	980141000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3626000	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2625000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	19139000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	102936000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-263455000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-235000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	844777000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	193526000	USD
CY2020Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5571000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	45573000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	71999000	USD
CY2020Q2	nkla	Shares Issued During Period Value Recapitalization SharesIssuedDuringPeriodValueRecapitalization	594522000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1882000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	38227000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-115782000	USD
CY2020Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2020Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	829947000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	195508000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	8403000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	56250000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	91999000	USD
	nkla	Shares Issued During Period Value Recapitalization SharesIssuedDuringPeriodValueRecapitalization	594522000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1884000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	39540000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-148928000	USD
CY2020Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2020Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	829947000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-263455000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-148928000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3710000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2926000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	102936000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	39540000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000	USD
	nkla	Non Cash In Kind Services NonCashInKindServices	27723000	USD
	nkla	Non Cash In Kind Services NonCashInKindServices	17241000	USD
	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	-1324000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1920000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1560000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	29157000	USD
	nkla	Issuance Of Stock For Commitment Shares IssuanceOfStockForCommitmentShares	2625000	USD
	nkla	Issuance Of Stock For Commitment Shares IssuanceOfStockForCommitmentShares	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1008000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2267000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4024000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	779000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9535000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9064000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7247000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4892000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-125974000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45561000	USD
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	64787000	USD
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	6303000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	25000000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	200000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-89587000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6303000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50349000	USD
	nkla	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	0	USD
	nkla	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	616736000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3839000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1884000	USD
	nkla	Proceeds From Finance Lease ProceedsFromFinanceLease	0	USD
	nkla	Proceeds From Finance Lease ProceedsFromFinanceLease	889000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	518000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	544000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4134000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4100000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4134000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	244000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1023000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	669314000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-216584000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	617450000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	849278000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89832000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	632694000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	707282000	USD
	us-gaap	Interest Paid Net InterestPaidNet	372000	USD
	us-gaap	Interest Paid Net InterestPaidNet	490000	USD
	nkla	Interest Received InterestReceived	384000	USD
	nkla	Interest Received InterestReceived	479000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	33389000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1371000	USD
	nkla	Accrued Deferred Issuance Costs AccruedDeferredIssuanceCosts	352000	USD
	nkla	Accrued Deferred Issuance Costs AccruedDeferredIssuanceCosts	0	USD
	nkla	Noncash Prepaid In Kind Services NoncashPrepaidInKindServices	0	USD
	nkla	Noncash Prepaid In Kind Services NoncashPrepaidInKindServices	74758000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	295000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	295000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	21919000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	145000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
	us-gaap	Stock Issued1 StockIssued1	2625000	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	32376000	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	632700000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	840900000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	632694000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	840913000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	698386000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	85688000	USD
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4365000	USD
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8896000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4000000	USD
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4144000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	632694000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	849278000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	707282000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89832000	USD
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	8895000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7335000	USD
CY2021Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y11M4D
CY2020Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y5M1D
CY2020Q2	nkla	Conversion Of Stock Shares Issued Conversion Rate ConversionOfStockSharesIssuedConversionRate	1.901
CY2020Q2	nkla	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	750000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	525000000	USD
	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	422000	USD
	nkla	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	616736000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	295000	USD
	nkla	Cash Recapitalization Net CashRecapitalizationNet	594522000	USD
CY2020Q2	nkla	Shares Issued During Period Shares Recapitalization SharesIssuedDuringPeriodSharesRecapitalization	72272942	shares
CY2020Q2	nkla	Common Stock Shares Outstanding Prior To Conversion CommonStockSharesOutstandingPriorToConversion	288631536	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	360904478	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	151831441	shares
CY2020Q2	nkla	Conversion Of Stock Shares Issued Conversion Rate ConversionOfStockSharesIssuedConversionRate	1.901
CY2021Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	2267000	USD
CY2021Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	USD
CY2021Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	2267000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	178353000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	79816000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11986000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8415000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	166367000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	71401000	USD
CY2021Q2	us-gaap	Depreciation Depreciation	1900000	USD
CY2020Q2	us-gaap	Depreciation Depreciation	1500000	USD
	us-gaap	Depreciation Depreciation	3600000	USD
	us-gaap	Depreciation Depreciation	2900000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1739000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1105000	USD
CY2021Q2	nkla	Accrued Stock Issuance Costs Current AccruedStockIssuanceCostsCurrent	637000	USD
CY2021Q2	nkla	Sale Of Stock Purchase Period SaleOfStockPurchasePeriod	36	USD
CY2020Q4	nkla	Accrued Stock Issuance Costs Current AccruedStockIssuanceCostsCurrent	285000	USD
CY2021Q2	nkla	Accrued Outsourced Engineering Services Current AccruedOutsourcedEngineeringServicesCurrent	7656000	USD
CY2020Q4	nkla	Accrued Outsourced Engineering Services Current AccruedOutsourcedEngineeringServicesCurrent	2514000	USD
CY2021Q2	nkla	Accrued Purchases Of Property And Equipment Current AccruedPurchasesOfPropertyAndEquipmentCurrent	5181000	USD
CY2020Q4	nkla	Accrued Purchases Of Property And Equipment Current AccruedPurchasesOfPropertyAndEquipmentCurrent	2533000	USD
CY2021Q2	nkla	Accrued Legal Liabilities Current AccruedLegalLiabilitiesCurrent	8547000	USD
CY2020Q4	nkla	Accrued Legal Liabilities Current AccruedLegalLiabilitiesCurrent	8845000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1804000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2457000	USD
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1161000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1070000	USD
CY2021Q2	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	26725000	USD
CY2020Q4	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	18809000	USD
CY2019Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0300
CY2021Q2	nkla	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	750000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2500000	USD
CY2020Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	29200000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1600000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	29200000	USD
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	8900000	USD
CY2021Q2	nkla	Issuance Of Stock For Commitment Shares IssuanceOfStockForCommitmentShares	2600000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	42802865	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	32529224	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.28
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M25D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2929917	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.24
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	39617	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.00
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	29559690	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.29
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M13D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	28782924	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.24
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y4M6D
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52670000	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38227000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	102936000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39540000	USD
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	391500000	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-143231000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-129189000	USD
CY2020Q3	nkla	Number Of Class Action Lawsuits NumberOfClassActionLawsuits	6	lawsuit
CY2020Q3	nkla	Number Of Derivative Actions NumberOfDerivativeActions	2	derivativeAction
CY2020Q4	nkla	Period Of Derivative Action PeriodOfDerivativeAction	P30D
CY2021Q1	nkla	Period Of Derivative Action PeriodOfDerivativeAction	P30D
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-143231000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-129189000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-263455000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-162335000	USD
CY2021Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2020Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-263455000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-162335000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	394577711	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	303785616	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	393390377	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	287822558	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	394577711	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	303785616	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	393390377	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	287822558	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53583579	shares
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	82126079	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53583579	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	82126079	shares

Files In Submission

Name	View Source	Status
0001731289-21-000102-index-headers.html	Edgar Link	pending
0001731289-21-000102-index.html	Edgar Link	pending
0001731289-21-000102.txt	Edgar Link	pending
0001731289-21-000102-xbrl.zip	Edgar Link	pending
a2020employeestockpurchase.htm	Edgar Link	pending
exhibit311q221.htm	Edgar Link	pending
exhibit312q221.htm	Edgar Link	pending
exhibit321q221.htm	Edgar Link	pending
exhibit322q221.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nkla-20210630.htm	Edgar Link	pending
nkla-20210630.xsd	Edgar Link	pending
nkla-20210630_cal.xml	Edgar Link	unprocessable
nkla-20210630_def.xml	Edgar Link	unprocessable
nkla-20210630_htm.xml	Edgar Link	completed
nkla-20210630_lab.xml	Edgar Link	unprocessable
nkla-20210630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NKLA
Nikola Corp Stock $nkla

2021 Q2 Form 10-Q Financial Statement

#000173128921000102 Filed on August 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NKLA Nikola Corp Stock $nkla

2021 Q2 Form 10-Q Financial Statement

#000173128921000102 Filed on August 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NKLA
Nikola Corp Stock $nkla